Displaying 1 - 3 of 3
| Active Ingredient | MORPHINE |
| Therapeutic Class | OPIATE AGONISTS |
| Indications | Severe visceral pain, post operative pain, terminal malignancies or bone pain, my ocardial infarction. |
| Caution | Drowsiness,nausea, vomiting, constipation,depression of respiration and cough. Urinary retention, tolerance and dependence. Advisable to use concurrent antiemetics and prophylaxis of constipation. |
| Dose Range |
Immediate release: 5-20mg every 4 hours. Loading dose may be required. Modified release given as once or twice daily dosing. See BDS supply protocols pg. 5. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | MORPHINE SULPHATE |
| Therapeutic Class | OPIATE AGONISTS |
| Indications | Severe visceral pain, post operative pain, terminal malignancies or bone pain, my ocardial infarction. |
| Caution | Drowsiness,nausea, vomiting, constipation,depression of respiration and cough. Urinary retention, tolerance and dependence. Advisable to use concurrent antiemetics and prophylaxis of constipation. |
| Dose Range |
Immediate release: 5-20mg every 4 hours. Loading dose may be required. Modified release given as once or twice daily dosing. See BDS supply protocols pg. 5. |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | MORPHINE SULPHATE SR |
| Therapeutic Class | OPIATE AGONISTS |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |